steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Company profile
Ticker
STE
Exchange
Website
CEO
Walter Rosebrough
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
STERIS Ltd
SEC CIK
Corporate docs
Subsidiaries
1666 E Touhy LLC • Accelera Technologies, LLC • Accutron, Inc. • Albert Browne Limited • American Sterilizer Company • Birkova Products, LLC • Bizworth Gammarad Sdn Bhd • Black Diamond Video, Inc. • Camark S.A. • Cantel (Belgium) BV ...
STE stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
11 Apr 24
10-Q
2024 Q3
Quarterly report
8 Feb 24
8-K
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
7 Feb 24
10-Q
2024 Q2
Quarterly report
7 Nov 23
8-K
STERIS Announces Financial Results for Fiscal 2024 Second Quarter
7 Nov 23
8-K/A
Submission of Matters to a Vote of Security Holders
7 Nov 23
10-Q
2024 Q1
Quarterly report
8 Aug 23
8-K
STERIS Announces Financial Results for Fiscal 2024 First Quarter
1 Aug 23
8-K/A
Departure of Directors or Certain Officers
27 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
27 Jul 23
Transcripts
STE
Earnings call transcript
2024 Q3
8 Feb 24
STE
Earnings call transcript
2024 Q2
8 Nov 23
STE
Earnings call transcript
2024 Q1
2 Aug 23
STE
Earnings call transcript
2023 Q4
11 May 23
STE
Earnings call transcript
2023 Q3
9 Feb 23
STE
Earnings call transcript
2023 Q2
10 Nov 22
STE
Earnings call transcript
2023 Q1
3 Aug 22
STE
Earnings call transcript
2022 Q4
12 May 22
STE
Earnings call transcript
2021 Q3
3 Feb 21
STE
Earnings call transcript
2021 Q2
3 Nov 20
Latest ownership filings
3
Kenneth E Kohler
23 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
9 Feb 24
SC 13G/A
BlackRock Inc.
9 Feb 24
SC 13G/A
WCM INVESTMENT MANAGEMENT, LLC
30 Jan 24
SC 13G/A
BlackRock Inc.
6 Dec 23
4
Andrew Xilas
6 Dec 23
4
Andrew Xilas
11 Oct 23
4
Karen L Burton
4 Oct 23
4
John Adam Zangerle
4 Oct 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 213.76 mm | 213.76 mm | 213.76 mm | 213.76 mm | 213.76 mm | 213.76 mm |
Cash burn (monthly) | (no burn) | 3.71 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 25.35 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 188.40 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 50.8 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
92.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 658 |
Opened positions | 80 |
Closed positions | 50 |
Increased positions | 231 |
Reduced positions | 245 |
13F shares | Current |
---|---|
Total value | 20.00 tn |
Total shares | 91.16 mm |
Total puts | 16.40 k |
Total calls | 184.20 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 11.81 mm | $2.59 tn |
BLK Blackrock | 9.60 mm | $2.11 tn |
Massachusetts Financial Services | 5.73 mm | $1.26 tn |
WCM Investment Management | 5.41 mm | $1.19 tn |
STT State Street | 4.14 mm | $907.66 bn |
MS Morgan Stanley | 3.97 mm | $870.48 bn |
APG Asset Management | 3.30 mm | $724.20 bn |
Geode Capital Management | 2.13 mm | $465.57 bn |
JHG Janus Henderson | 2.10 mm | $459.92 bn |
T. Rowe Price | 1.53 mm | $336.78 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Dec 23 | Andrew Xilas | Ordinary Shares | Payment of exercise | Dispose F | No | No | 199.27 | 98 | 19.53 k | 6,471 |
4 Dec 23 | Andrew Xilas | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 333 | 0.00 | 6,569 |
4 Dec 23 | Andrew Xilas | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 333 | 0.00 | 0 |
9 Oct 23 | Andrew Xilas | Ordinary Shares | Payment of exercise | Dispose F | No | No | 225.81 | 178 | 40.19 k | 6,236 |
9 Oct 23 | Andrew Xilas | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 605 | 0.00 | 6,414 |
9 Oct 23 | Andrew Xilas | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 605 | 0.00 | 333 |
2 Oct 23 | Julia Madsen | Ordinary Shares | Payment of exercise | Dispose F | No | No | 215.5 | 171 | 36.85 k | 8,551 |
2 Oct 23 | Andrew Xilas | Ordinary Shares | Payment of exercise | Dispose F | No | No | 215.5 | 85 | 18.32 k | 5,809 |
News
Needham Reiterates Hold on Steris
12 Apr 24
STERIS Enters Definitive Deal To Divest Its Dental Segment To Peak Rock Capital For $787.5M
11 Apr 24
What 4 Analyst Ratings Have To Say About Steris
9 Feb 24
Stephens & Co. Reiterates Overweight on Steris, Maintains $250 Price Target
9 Feb 24
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
8 Feb 24
Press releases
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
24 Apr 24
PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP
11 Apr 24
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
11 Apr 24
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
7 Feb 24
STERIS Announces Dividend of $0.52 per share
30 Jan 24